Vera Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	57.77	92.65	45.68	43.46	79.67	53.65
Short-Term Investments	439.62	548.21	115.04	71.19	-	0.09
Cash & Short-Term Investments	497.39	640.85	160.72	114.65	79.67	53.74
Cash Growth	40.78%	298.75%	40.18%	43.90%	48.26%	1564.29%
Other Receivables	3.36	3.77	0.51	-	-	0.05
Receivables	3.36	3.77	0.51	-	-	0.05
Prepaid Expenses	9.42	5.68	8.56	10.33	2.38	0.03
Restricted Cash	-	-	-	-	-	0.05
Other Current Assets	1.15	0.91	2.24	0.72	0.48	0.39
Total Current Assets	511.31	651.22	172.02	125.7	82.54	54.26
Property, Plant & Equipment	3.19	4.33	3.04	5.22	-	-
Long-Term Investments	-	-	-	0.06	0.87	-
Other Long-Term Assets	3	0.13	0.48	0.46	0.34	0.29
Total Assets	517.5	655.68	175.55	131.44	83.75	54.55
Accounts Payable	17.95	7.67	11.12	11.99	1.39	0.91
Accrued Expenses	23.46	16.22	8.75	10.96	5.93	0.54
Current Portion of Leases	0.47	1.48	2.44	2.65	-	-
Other Current Liabilities	-	-	-	-	0.38	0.96
Total Current Liabilities	41.88	25.37	22.3	25.6	7.69	2.41
Long-Term Debt	74.65	50.69	49.88	24.81	4.92	-
Long-Term Leases	2.1	2.47	1.4	3.83	-	-
Other Long-Term Liabilities	-	-	0.29	0.29	1.54	1.92
Total Liabilities	118.62	78.53	73.86	54.53	14.16	4.33
Common Stock	0.06	0.06	0.04	0.03	0.02	-
Additional Paid-In Capital	1,068	1,038	410.49	290.22	193.63	2.1
Retained Earnings	-669.77	-461.25	-309.1	-213.11	-124.06	-91.45
Comprehensive Income & Other	0.88	0.39	0.25	-0.22	-	-
Total Common Equity	398.88	577.16	101.69	76.91	69.59	-89.35
Shareholders' Equity	398.88	577.16	101.69	76.91	69.59	50.23
Total Liabilities & Equity	517.5	655.68	175.55	131.44	83.75	54.55
Total Debt	77.22	54.64	53.71	31.29	4.92	-
Net Cash (Debt)	420.17	586.21	107.01	83.37	74.75	53.74
Net Cash Growth	40.81%	447.82%	28.36%	11.53%	39.10%	1635.23%
Net Cash Per Share	6.67	10.60	2.51	3.14	5.56	167.96
Filing Date Shares Outstanding	63.93	63.75	54.45	44.26	27.05	0.36
Total Common Shares Outstanding	63.89	63.56	44.45	27.8	21.28	0.36
Working Capital	469.43	625.85	149.72	100.1	74.85	51.86
Book Value Per Share	6.24	9.08	2.29	2.77	3.27	-251.47
Tangible Book Value	398.88	577.16	101.69	76.91	69.59	-89.35
Tangible Book Value Per Share	6.24	9.08	2.29	2.77	3.27	-251.47

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q